Lincoln National Corp’s Chemours CC Stock Holding History

Lincoln National Corp’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6,081	Closed	-$212K	–	867
2021 Q2	$212K	Buy	+6,081	New	+$201K	﹤0.01%	792
2020 Q2	–	Sell	-14,093	Closed	-$125K	–	649
2020 Q1	$125K	Buy	+14,093	New	+$203K	﹤0.01%	554

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Lincoln National Corp's CC Position: Q3 2021 in Review

Lincoln National Corp sold out of Chemours (CC) in Q3 2021, closing a stake of 6,081 shares — an estimated $212K sold.

Lincoln National Corp first reported a position in CC in Q1 2020 and held it in 2 quarters. The position peaked at $212K in Q2 2021. 460 funds tracked by Wall St. Rank hold CC as of Q3 2021.

Lincoln National Corp reported no remaining Chemours position as of Q3 2021 after selling out during the quarter.
Lincoln National Corp sold 6,081 Chemours shares in Q3 2021, an estimated $212K.
Lincoln National Corp first reported a position in Chemours in Q1 2020 and held it in 2 quarters.
Lincoln National Corp's Chemours position peaked at $212K in Q2 2021.
460 funds tracked by Wall St. Rank held Chemours as of Q3 2021.

Based on Lincoln National Corp's 13F filing for Q3 2021, filed 5 Nov 2021.